David Guenoun

Dr. David Guenoun

Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
orcid
Post-doctorate researcher

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Glia
Verified
Journal Article
Open access
DGDavid Guenoun
David Guenoun
NBNathan Blaise
Nathan Blaise
ASAlexandre Sellam
Alexandre Sellam
JRJulie Roupret‐Serzec
Julie Roupret‐Serzec
AJAlice Jacquens
Alice Jacquens
CBCindy Bokobza
Cindy Bokobza
A growing body of evidence highlights the importance of microglia, the resident immune cells of the CNS, and their pro‐inflammatory activation in the onset of many neurological diseases. Microglial proliferation, differentiation, and survival are highly dependent on the CSF‐1 signaling pathway, which can be pharmacologically modulated by inhibiting its receptor, CSF‐1R. Pharmacological inhibition of CSF‐1R leads to an almost complete microglial depletion whereas treatment arrest allows for subsequent repopulation. Microglial depletion has shown promising results in many animal models of neurodegenerative diseases (Alzheimer's disease (AD), Parkinson's disease, or multiple sclerosis) where transitory microglial depletion reduced neuroinflammation and improved behavioral test results. In this review, we will focus on the comparison of three different pharmacological CSF‐1R inhibitors (PLX3397, PLX5622, and GW2580) regarding microglial depletion. We will also highlight the promising results obtained by microglial depletion strategies in adult models of neurological disorders and argue they could also prove promising in neurodevelopmental diseases associated with microglial activation and neuroinflammation. Finally, we will discuss the lack of knowledge about the effects of these strategies on neurons, astrocytes, and oligodendrocytes in adults and during neurodevelopment.

Verified
Journal Article
Open access
PDF file
CMCécile Morin
Cécile Morin
DGDavid Guenoun
David Guenoun
ISIrvin Sautet
Irvin Sautet
VFValérie Faivre
Valérie Faivre
ZCZsolt Csaba
Zsolt Csaba
CBCindy Bokobza
Cindy Bokobza
Preterm birth (PTB) represents 15 million births every year worldwide and is frequently associated with maternal/fetal infections and inflammation, inducing neuroinflammation. This neuroinflammation is mediated by microglial cells, which are brain-resident macrophages that release cytotoxic molecules that block oligodendrocyte differentiation, leading to hypomyelination. Some preterm survivors can face lifetime motor and/or cognitive disabilities linked to periventricular white matter injuries (PWMIs). There is currently no recommendation concerning the mode of delivery in the case of PTB and its impact on brain development. Many animal models of induced-PTB based on LPS injections exist, but with a low survival rate. There is a lack of information regarding clinically used pharmacological substances to induce PTB and their consequences on brain development. Mifepristone (RU-486) is a drug used clinically to induce preterm labor. This study aims to elaborate and characterize a new model of induced-PTB and PWMIs by the gestational injection of RU-486 and the perinatal injection of pups with IL-1beta. A RU-486 single subcutaneous (s.c.) injection at embryonic day (E)18.5 induced PTB at E19.5 in pregnant OF1 mice. All pups were born alive and were adopted directly after birth. IL-1beta was injected intraperitoneally from postnatal day (P)1 to P5. Animals exposed to both RU-486 and IL-1beta demonstrated microglial reactivity and subsequent PWMIs. In conclusion, the s.c. administration of RU-486 induced labor within 24 h with a high survival rate for pups. In the context of perinatal inflammation, RU-486 labor induction significantly decreases microglial reactivity in vivo but did not prevent subsequent PWMIs.

23 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CMCécile Morin
Cécile Morin
FFFlora Faure
Flora Faure
DGDavid Guenoun
David Guenoun
ISIrvin Sautet
Irvin Sautet
SDSihao Diao
Sihao Diao
CBCindy Bokobza
Cindy Bokobza
Infants born very preterm (below 28 weeks of gestation) are at high risk of developing neurodevelopmental disorders, such as intellectual deficiency, autism spectrum disorders, and attention deficit. Preterm birth often occurs in the context of perinatal systemic inflammation due to chorioamnionitis and postnatal sepsis (Dammann, O. and Leviton, A., Intermittent or sustained systemic inflammation and the preterm brain . Pediatr Res, 2014. 75 (3): p. 376-80). In addition, C-section is often performed for very preterm neonates to avoid hypoxia during a vaginal delivery (Luca, A.,et al., Birth trauma in preterm spontaneous vaginal and cesarean section deliveries: A 10-years retrospective study. PloS one,2022, 17(10), e0275726.) We have developed and characterized a mouse model based on intraperitoneal injections of IL-1β between postnatal days one and five to reproduce perinatal systemic inflammation (Favrais, G.,et al., Systemic inflammation disrupts the developmental program of white matter. Ann Neurol,2011. 70 (4): p. 550-65). This model replicates several neuropathological, brain imaging, and behavioral deficits observed in preterm infants. We hypothesized that C-sections could synergize with systemic inflammation to induce more severe brain abnormalities. We observed that C-sections significantly exacerbated the deleterious effects of IL-1β on reduced gut microbial diversity, increased levels of circulating peptidoglycans, abnormal microglia/macrophage reactivity, impaired myelination, and reduced functional connectivity in the brain relative to vaginal delivery plus intraperitoneal saline. These data demonstrate the deleterious synergistic effects of C-section and neonatal systemic inflammation on brain maldevelopment and malfunction, two conditions frequently observed in very preterm infants, who are at high risk of developing neurodevelopmental disorders. Significance Statement: In a well-established mouse model of the encephalopathy of prematurity, we observed that C-section exacerbates the deleterious effects of neonatal systemic inflammation (intraperitoneal injections of IL-1β between postnatal days one and five) on reduced gut microbial diversity, increased levels of circulating peptidoglycans, abnormal microglia/macrophage reactivity, impaired myelination, and reduced brain functional connectivity. These data demonstrate the deleterious synergistic effects of C-section and neonatal systemic inflammation, two conditions frequently observed in very preterm infants, who are at high risk of developing neurodevelopmental disorders.

25 July 2022 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
CBCindy Bokobza
Cindy Bokobza
AJAlice Jacquens
Alice Jacquens
MZManuela Zinni
Manuela Zinni
VFValérie Faivre
Valérie Faivre
JHJennifer Hua
Jennifer Hua
JSJuliette Van Steenwinckel
Juliette Van Steenwinckel
Microglia, as brain resident macrophages, are fundamental to several functions, including response to environmental stress and brain homeostasis. Microglia can adopt a large spectrum of activation phenotypes. Moreover, microglia that endorse pro-inflammatory phenotype is associated with both neurodevelopmental and neurodegenerative disorders. In vitro studies are widely used in research to evaluate potential therapeutic strategies in specific cell types. In this context studying microglial activation and neuroinflammation in vitro using primary microglial cultures is more relevant than microglial cell lines or stem-cell-derived microglia. However, the use of some primary cultures might suffer from a lack of reproducibility. This protocol proposes a reproducible and relevant method of magnetically isolating microglia from neonate pups. Microglial activation using several stimuli after 4 h and 24 h by mRNA expression quantification and a Cy3-bead phagocytic assay is demonstrated here. The current work is expected to provide an easily reproducible technique for isolating physiologically relevant microglia from juvenile developmental stages.

27 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DJDaniela Jacobsohn
Daniela Jacobsohn
DGDavid Guenoun
David Guenoun
NHNathalie Hertrich
Nathalie Hertrich
PFPascal Fenske
Pascal Fenske
SPSabrina Pommer
Sabrina Pommer
AKAngela M. Kaindl
Angela M. Kaindl
Epilepsy is one of the most common neurological disorders, affecting more than 50 million people worldwide. Among the genetic etiologies of epilepsy, variants in genes coding for ion channels are vastly represented and characterized. Notably, loss-of-function (LoF) mutations in voltage-gated sodium channels (Na V ) genes can result in a wide range of phenotypes including West syndrome, autism spectrum disorder, or Dravet Syndrome. Although the implication of Na V subtypes in epileptic syndromes and the relationship between seizures and inflammation have been extensively described, subtype-specific neuronal responses to inflammation in the context of Na V loss-of-function remain poorly understood. In this study, we investigated the consequences of subtype-specific downregulation of Na V expression in primary mouse cortical neurons. Using shRNA-mediated silencing of Scn1a , Scn2a , or Scn8a , we generated neuronal cultures with reduced expression of Na V 1.1, Na V 1.2, or Na V 1.6 and evaluated neuronal survival, inflammatory gene expression, and global transcriptomic responses under basal conditions and following an inflammatory challenge. Subtype-specific Na V downregulations did not produce a uniform phenotype. Rather, minor differences under basal conditions led to important discrepancies following exposure to an inflammatory stimulus. Notably, Na V 1.1 reduction was associated with synaptic transcriptional changes, whereas Na V 1.6 downregulation led to a substantial inflammatory signaling remodeling. Our observations suggest that the consequences of Na V dysfunction are not only determined by their role in neuronal excitability but also depend on subtype-specific responses to inflammatory cues. They notably shed light on the relevance of inflammatory events in the onset and progression of epileptic syndromes related to Na V loss-of-function mutations.

8 April 2026
Verified
Thesis
Closed access
DGDavid Guenoun
David Guenoun
Exploring the long-term consequences of prematurity : study of the impact of an early life inflammatory event on inflammaging and pathological ageing: Les processus inflammatoires jouent un rôle crucial dans la physiopathologie de nombreuses maladies. C'est le cas des pathologies de l'enfant prématuré et des maladies liées à l'âge (MLA), respectivement liées à l'inflammation périnatale et à l'inflammaging. Plus de 40 % des naissances prématurées sont concernées par un syndrome inflammatoire périnatal. Ce dernier est responsable de l'émergence de processus neuroinflammatoires, facteurs de risque majeur de lésions cérébrales périnatales (LCP) et de troubles du neurodéveloppement chez l'enfant prématuré. L'inflammaging décrit, lui, un syndrome inflammatoire chronique, stérile et progressif associé au vieillissement et à l'apparition de MLA (métaboliques, neurologiques, etc...). Devant l'amélioration du taux de survie des prématurés, la question du vieillissement de ces enfants, soumis à ces deux processus inflammatoires, se pose. Dans ce contexte, la réactivité microgliale joue un rôle central. Elle est directement responsable de l'apparition des LCP et est associée au vieillissement pathologique (i.e. impliquant des MLA). La microglie est, de plus, sensible au priming cellulaire, un mécanisme par lequel les cellules immunitaires réagissent plus rapidement et plus fortement à des stimuli inflammatoires secondaires. Nous émettons, ici, l'hypothèse qu'à la suite d'un évènement inflammatoire périnatal tel que la prématurité, la microglie acquiert un état « primé », cause de sa réactivité excessive au cours de l'inflammaging. En conséquence, ce phénomène pourrait orienter vers la voie du vieillissement pathologique et causer l'apparition précoce de MLA chez les adultes nés prématurés. Dans un modèle de LCP induit par des injections répétées d'interleukine-1-bêta (IL-1β) pendant les cinq premiers jours de vie des animaux, nous avons étudié les effets de l'inflammation périnatale chez des souris âgées de 7 mois. Notre premier axe d'étude s'est porté sur les conséquences périphériques et métaboliques tardives de l'inflammation périnatale. Nos résultats suggèrent que l'inflammation périnatale induit une augmentation de l'état inflammatoire supérieur et perturbe le métabolisme glucidique chez les souris mâles (résistance à l'insuline, à la leptine, et intolérance au glucose) à 7 mois. Nous avons, ensuite, étudié les anomalies neurologiques tardives associées aux LCP dans de même modèle. Grâce à une approche multi-techniques, nous avons montré l'existence d'une augmentation de la réactivité microgliale, d'une hypomyélinisation, d'anomalies de la substances grise, ainsi que de troubles de la connectivité cérébrale et du comportement chez les souris ayant subi une inflammation périnatale. Enfin, nous avons évalué le potentiel thérapeutique de cellules souches mésenchymateuses humaines (HuMSC) dans le traitement des séquelles des LCP. En utilisant une méthode de criblage à haut débit, nous avons déterminé le meilleur protocole d'administration de ces cellules et avons montré que leur administration intranasale à 20 jours de vie réduit efficacement les lésions de la substance blanche dans notre modèle de LCP.Ce travail illustre les bénéfices neurologiques pouvant être obtenus par des stratégies de normalisation de la réactivité microgliale persistante. Ces études appuient, de plus, le besoin d'un suivi précis et systématique des anciens prématurés et ouvrent la voie à de nouvelles stratégies préventives et thérapeutiques.